Novocell announces non-exclusive drug discovery collaboration with Pfizer
Novocell, Inc., a stem cell engineering company, today announced it has entered into a non-exclusive drug discovery collaboration with Pfizer giving Pfizer access to Novocell's proprietary pancreatic progenitor cells derived from human embryonic stem cells.
Astex Therapeutics, the leading fragment-based drug discovery company, today announced that it has successfully achieved two scientific milestones in its drug discovery collaboration with Janssen Pharmaceutica NV.